Serum cytokine levels in patients with advanced non-small cell lung cancer: Correlation with treatment response and survival

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1453-1457

  Su, Chunxia ^a   Zhou, Caicun ^a   Zhou, Songwen ^a   Xu, Jianfang ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chemoresponse; Chemotherapy; Cytokines; Non small cell lung cancer; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; GAMMA INTERFERON; GEMCITABINE; INTERLEUKIN 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 6; NAVELBINE; PACLITAXEL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CHINESE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL;

EID: 84655165033     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9645-6     Document Type: Article

References (16)

1. C Camps R Sirera V Iranzo M Tarón R Rosell 2007 Gene expression and polymorphisms of DNA repair enzymes: cancer susceptibility and response to chemotherapy Clin Lung Cancer 8 6 369 375
2. A Matakidou R el Galta EL Webb MF Rudd H Bridle GELCAPS Consortium 2007 Genetic variation in the DNA repair genes is predictive of outcome in lung cancer Hum Mol Genet 16 2333 2340
3. W Zhou S Gurubhagavatula G Liu S Park DS Neuberg JC Wain 2004 Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy Clin Cancer Res 1;10 15 4939 4943
4. D Derin HO Soydinç N Guney F Tas H Camlica D Duranyildiz 2008 Serum levels of apoptosis biomarkers, survivin and TNF-alpha in non-small cell lung cancer Lung Cancer 59 2 240 245
5. AZ Dudek H Mahaseth 2005 Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival Cancer Invest 23 3 193 200
6. F Tas D Duranyildiz H Oguz H Camlica V Yasasever E Topuz 2006 Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancer Cancer Invest 24 5 492 496
7. WC Liao JT Lin CY Wu SP Huang MT Lin AS Wu 2008 Serum interleukin-6 level but not genotype predicts survival after resection in stages ii and iii gastric carcinoma Clin Cancer Res 15;14 2 428 434
8. W Naumnik E Chyczewska O Kovalchuk J Tałałaj T Izycki B Panek 2004 Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer Rocz Akad Med Bialymst 49 246 251
9. PA Bunn Jr K Kelly 1998 New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions Clin Cancer Res 5 1087 1100
10. RM Rudd NH Gower LE James W Gregory T Eisen S Lee 2002 Phase III randomized comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC) Proc Am Soc Clin Oncol 21 292a
11. GV Scagliotti F De Marinis M Rinaldi L Crino C Gridelli S Ricci 2002 Phase III randomized trial comparing three platinum-based doublets in advanced non-small cell lung cancer J Clin Oncol 20 4285 4291
12. R Rosell C Manegold T Moran P Garrido R Blanco P Lianes 2008 Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer Clinical Lung Cancer 9 Suppl. 2 S76 S82
13. M Łukaszewicz B Mroczko M Szmitkowski 2007 Clinical significance of interleukin-6 (IL-6) as a prognostic factor of cancer disease Pol Arch Med Wewn 117 5-6 247 251
14. JB Welsh LM Sapinoso SG Kern DA Brown T Liu AR Bauskin 2003 Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum Proc Natl Acad Sci U S A 18;100 6 3410 3415
15. A Siemińska 2004 The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients Pol Merkur Lekarski 16 92 188 190
16. LH Song XR Song MQ Liu XQ Zhang L Zheng XJ Li 2004 Prognostic factors in patients with stage III and IV non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 26 6 345 348